Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Nishant Shah

Anesthesiology Chicago, IL Medical Doctor

NPI 1043412992 CMS profile 421595

820 S. Damen Avenue, Anesthesiology Service Room 2672, Chicago, IL 60612

Open in the dashboard

General payments

$2,139,276

141 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Nishant Shah of Chicago, IL is reported in the CMS Open Payments database as having received $2,139,276 across 141 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Anesthesiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $15,783 11
2024 General $20,269 25
2023 General $9,030 17
2022 General $449 4
2021 General $12,032 12
2020 General $2,038,942 22
2019 General $42,770 50

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nishant Shah
  • Anesthesiology median
  • Middle half of Anesthesiology
  • National median

In program year 2025, general payments to Nishant Shah were reported at $15,783. Among 18,548 Anesthesiology profiles paid that year, the median was $58 and the middle half received between $26 and $153.

Show as a table
Year Nishant Shah Anesthesiology median Middle half National median
2019 $42,770 $72 $23–$151 $163
2020 $2,038,942 $36 $17–$120 $114
2021 $12,032 $49 $21–$135 $132
2022 $449 $52 $22–$144 $149
2023 $9,030 $53 $23–$143 $160
2024 $20,269 $55 $25–$150 $164
2025 $15,783 $58 $26–$153 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $2,069,836 64 payments
  2. Medline Industries, Inc. $39,207 23 payments
  3. CSL Plasma Inc. $17,670 34 payments
  4. Medical Device Business Services, Inc. $5,563 3 payments
  5. AcelRx Pharmaceuticals, Inc. $2,981 4 payments
  6. Heron Therapeutics, Inc. $1,869 4 payments
  7. Butterfly Network, Inc. $1,600 1 payment
  8. MicroPort Orthopedics Inc $400 3 payments
  9. UCB, Inc. $83 1 payment
  10. Radius Health, Inc. $40 2 payments
  11. Other $27 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $2,000,000 2 payments
  2. Consulting Fee $71,166 59 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $57,878 28 payments
  4. Travel and Lodging $5,736 22 payments
  5. Food and Beverage $2,496 29 payments
  6. Honoraria $2,000 1 payment
Products named General payments · program years 2019–2025
  1. ARIA $2,000,000 2 payments
  2. POLARSTEM $13,961 15 payments
  3. Dermatology and Wound Care $13,395 5 payments
  4. R3 $12,150 7 payments
  5. Anthology $10,674 8 payments
  6. Oxinium Hips $10,530 6 payments
  7. Navio Surgical System $9,174 14 payments
  8. JOURNEY II BCS $7,700 5 payments
  9. POLARCUP $7,117 6 payments
  10. JOURNEY II $6,750 4 payments
  11. Other $71,103 93 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 24 billing codes

Paid by Medicare

$6,022

Medicare's payments for the services billed

Medicare patients

51

Average age 76

Services billed

53

33 women, 18 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 65%
Diabetes 35%
Chronic kidney disease 27%
Ischemic heart disease 25%
Atrial fibrillation 25%
Heart failure 24%
Osteoporosis 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

141 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Anesthesiology in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record